Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans (Q44797399)

6 December 2017

title

Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans (English)

1 reference

6 December 2017

1 reference

7

Alan R Zinsmeister

1 reference

6 December 2017

2

Michael Camilleri

1 reference

6 December 2017

6

Sanna McKinzie

1 reference

6 December 2017

5

Duane Burton

1 reference

6 December 2017

4

Silvia Delgado-Aros

1 reference

6 December 2017

1

Heather J Chial

1 reference

6 December 2017

3

Irene Ferber

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Clinical Gastroenterology and Hepatology

6 December 2017

published in

1 reference

6 December 2017

volume

1

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

211-218

1 reference

Gastrointestinal illness and the biopsychosocial model

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Diagnosing and treating patients with refractory functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Antidepressants for functional gastrointestinal syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acung through 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Evidence of the dual mechanisms of action of venlafaxine

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

A patient questionnaire to identify bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Contractile activity of the human colon: lessons from 24 hour studies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

Regional cerebral activity in normal and pathological perception of visceral pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2970038-X

7 January 2021

10.1016/S1542-3565(03)70038-X

Identifiers

DOI

1 reference

6 December 2017

1 reference